A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus

The 2022 global outbreaks of monkeypox virus (MPXV) and increased human-to-human transmission calls for the urgent development of countermeasures to protect people who cannot benefit from vaccination. Here, we describe the development of glycovariants of 7D11, a neutralizing monoclonal IgG antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Esqueda, Adrian, Sun, Haiyan, Bonner, James, Lai, Huafang, Jugler, Collin, Kibler, Karen V., Steinkellner, Herta, Chen, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416152/
https://www.ncbi.nlm.nih.gov/pubmed/37514995
http://dx.doi.org/10.3390/vaccines11071179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416152/
https://www.ncbi.nlm.nih.gov/pubmed/37514995
http://dx.doi.org/10.3390/vaccines11071179

Ejemplares similares